Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ETCompany ParticipantsFrancesca DeMartino - Senior Vice President, ...

Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...

Chico’s Growth and Community Development Committee discussed Valley’s Edge and the group’s next steps Tuesday.

Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.

Scientists have made a surprising discovery: they have managed to manipulate light particles in such a way that they can ...

If I had to rank motions I dislike the most, Rule 12, that motion to strike has got to be up there,” Judge Rodolfo A. Ruiz II ...

Q4 2024 Earnings Call Transcript February 6, 2025 Pinterest, Inc. beats earnings expectations. Reported EPS is $2.68, expectations were $0.63. Andrew Somberg: Good afternoon. Thank you for attending ...

The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

Preparing to Initiate Clinical Development in Patients with Hematologic Malignancies in the First Quarter of 2025Series B Financing Funds ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Lung transplant recipients are highly susceptible to infection, the researchers noted, and P. aeruginosa is a leading cause ...